ScholarIQanswers from OpenAlex & ORCID
Mark Emberton
ResearcherPublications, citations & collaboration network
Mark Emberton is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark Emberton have?
ScholarIQindexed works
Mark Emberton has 1,015 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark Emberton have?
ScholarIQcitation count
Mark Emberton has 39,312 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark Emberton?
ScholarIQh-index
Mark Emberton has an h-index of 89 in OpenAlex.
What is the i10-index of Mark Emberton?
ScholarIQi10-index
Mark Emberton has an i10-index of 403 in OpenAlex.
What is the ORCID of Mark Emberton?
ScholarIQorcid
The ORCID for Mark Emberton is on the source record.
What is the OpenAlex record for Mark Emberton?
ScholarIQopenalex
The OpenAlex for Mark Emberton is on the source record.
What are the most-cited papers on Mark Emberton?
ScholarIQmost cited works
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan, Antti Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A. Mynderse, Markku H. Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard Hindley, Monique J. Roobol, Scott E. Eggener, Maneesh Ghei, Arnauld Villers, Franck Bladou, Geert Villeirs, Jaspal Virdi, Silvan Boxler, G. Robert, Paras B. Singh, Wulphert Venderink, Boris Hadaschik, A. Ruffion, Jim C. Hu, Daniel Margolis, Sébastien Crouzet, Laurence Klotz, Samir S. Taneja, Peter A. Pinto, Inderbir S. Gill, Clare Allen, Francesco Giganti, Alex Freeman, Stephen Morris, Shonit Punwani, Norman Williams, Chris Brew‐Graves, Jonathan J Deeks, Yemisi Takwoingi, Mark Emberton, Caroline M. Moore
Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group
Caroline M. Moore, Veeru Kasivisvanathan, Scott Eggener, Mark Emberton, Jurgen J. Fütterer, Inderbir S. Gill, Robert L. Grubb, Boris Hadaschik, Laurence Klotz, Daniel Margolis, Leonard S. Marks, Jonathan Melamed, Aytekin Oto, Suzanne L. Palmer, Peter A. Pinto, Philippe Puech, Shonit Punwani, Andrew B. Rosenkrantz, Ivo G. Schoots, Richard Simon, Samir S. Taneja, Barış Türkbey, Osamu Ukimura, Jan van der Meulen, Arnauld Villers, Yuji Watanabe
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret, Antony Cicco, F. Kleinclauss, Henk G. van der Poel, Christian G. Stief, Jens Rassweiler, Georg Salomon, Eduardo Solsona, Antonio Alcaraz, Teuvo T. L. Tammela, Derek J. Rosario, F. Gómez-Veiga, Göran Ahlgren, Fawzi Benzaghou, B. Gaillac, Billy Amzal, F.M.J. Debruyne, Gaëlle Fromont, Christian Gratzke, Mark Emberton
Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care
Osamu Ukimura, Jonathan Coleman, A. De La Taille, Mark Emberton, Jonathan I. Epstein, Stephen J. Freedland, Gianluca Giannarini, Adam S. Kibel, Rodolfo Montironi, Guillaume Ploussard, Monique J. Roobol, Vincenzo Scattoni, J. Stephen Jones